Ten63 Therapeutics

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable. Ten63 Therapeutics is based in Durham, NC and was founded in 2018. It was valued at $979 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $50.5 million across 1 recorded round; the latest was a $2.1 million seed round in Jan 2021.

PMV mark · valuation
$979.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$50.5M
Last round
Seed Round
Jan 2021
What is Ten63 Therapeutics worth?
$979.0MPrivateMarketView mark · Oct 2026

Valued at $979.0M at its later-stage round, Jan 2025. Nothing has traded since.

Free account
More of Ten63 Therapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Ten63 Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Ten63 Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Jan 2021Seed Round$2.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Ten63 Therapeutics valuation

Ten63 Therapeutics was valued at $979 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Ten63 Therapeutics raised?

Ten63 Therapeutics has raised $50.5 million in total; 1 of its rounds is on record. The largest on record was a $2.1 million seed round in Jan 2021.

Ten63 Therapeutics has filed 1 Form D with the SEC, most recently in Jan 2021 ($2.1 million sold to 7 investors).

How Ten63 Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ten63 Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Ten63 Therapeutics

What is Ten63 Therapeutics worth?
Ten63 Therapeutics is valued at $979.0M as of Oct 2026. Valued at $979.0M at its later-stage round, Jan 2025. Nothing has traded since.
How much has Ten63 Therapeutics raised?
Ten63 Therapeutics has raised $50.5M in total funding across 1 recorded rounds.
When did Ten63 Therapeutics last raise?
Ten63 Therapeutics last raised in Jan 2021 (Seed Round), raising $2.1M.